Management Office
c/o Congress Corporation
Kohsai-kaikan Bldg., 5-1
Kojimachi, Chiyoda-ku, Tokyo
102-8481, Japan
Tel: +81-3-5216-5318
E-mail: jua2019@congre.co.jp
JUA Secretariat
The Japanese Urological Association
2-17-15 Yushima
Bunkyo-Ward Tokyo
113-0034, Japan
E-mail: office@urol.or.jp
Abstract Submission has been closed.
The Scientific Committee will review all abstracts, and you will be notified by February, 2019 whether your abstract has been accepted.
The decision of the Scientific Committee is final.
All abstracts accepted will be published in the program book that will be distributed to conference attendees.
There will be 2 sessions at JUA 2019.
The first author of the presentation must disclose all necessary information in the provided COI form at the time of abstract submission.
1 | Adrenals | 12 | Neuro-urology |
---|---|---|---|
2 | Upper tract benign disease | 13 | Incontinence |
3 | Kidney transplantation | 14 | Infertility |
4 | Renal tumors | 15 | Andrology |
5 | Urothelial tumors | 16 | Sexual dysfunction |
6 | Urinary reconstruction | 17 | Infectious disease |
7 | Prostate cancer | 18 | Stones |
8 | Testis tumors | 19 | Trauma and emergencies |
9 | Penile cancer | 20 | Pediatric urology |
10 | Male LUTS | 21 | Urethroplasty and genital reconstruction |
11 | Female LUTS | 22 | Others |
Abstracts must be submitted in English, not exceeding 1600 characters.
The material for presentation should be unpublished and original.
Abstract Submission
Should you need further information, please contact us.
Congress Corporation.
E-mail: jua2019@congre.co.jp